Leila Alland - Sep 9, 2021 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role: Chief Medical Officer
Signature: /s/ Winston Kung, by power of attorney
Stock symbol: PMVP
Transactions as of: Sep 9, 2021
Transactions value $: -$2,635
Form type: 4
Date filed: 9/10/2021, 04:14 PM
Previous filing: Sep 8, 2021
Next filing: Feb 28, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PMVP	Common Stock	Options Exercise	$390	+100		$3.90	100	Sep 9, 2021	Direct
transaction	PMVP	Common Stock	Sale	-$3.03K	-100	-100%	$30.25	0	Sep 9, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PMVP	Employee Stock Option (right to buy)	Options Exercise	$0	-100	-0.03%	$0.00	354K	Sep 9, 2021	Common Stock	100	$3.90	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020.
F2	One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter.